As companies seek maturity in multichannel commercial models, there’s one key problem for those operating in Europe: European countries lag behind the US and Japan significantly in terms of the volume share and relative impact of digital contacts with prescribers - and whilst digital is by no means the entirety of multichannel, it’s impossible to imagine a mature model without it.